Markets & Stocks
MGC Pharma to Rebrand to Argent BioPharma, OCT Explores Capital Reorganisation, & Cannabis Poland’s Stock Skyrockets
MGC Pharmaceuticals / Argent BioPharma [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals has become the latest UK-listed cannabis company to opt for a rebrand in 2024, as businesses increasingly try to diversify and distance themselves from the difficulties experienced across the cannabis sector over the last year…
